Crossmark Global Holdings’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.12M Buy
9,133
+1,252
+16% +$154K 0.02% 573
2025
Q1
$798K Sell
7,881
-34
-0.4% -$3.44K 0.01% 679
2024
Q4
$731K Sell
7,915
-37
-0.5% -$3.42K 0.01% 681
2024
Q3
$769K Buy
7,952
+612
+8% +$59.2K 0.01% 695
2024
Q2
$630K Sell
7,340
-586
-7% -$50.3K 0.01% 740
2024
Q1
$655K Sell
7,926
-153
-2% -$12.6K 0.01% 755
2023
Q4
$539K Sell
8,079
-683
-8% -$45.6K 0.01% 812
2023
Q3
$577K Sell
8,762
-641
-7% -$42.2K 0.01% 755
2023
Q2
$621K Sell
9,403
-82
-0.9% -$5.42K 0.01% 747
2023
Q1
$513K Sell
9,485
-56
-0.6% -$3.03K 0.01% 814
2022
Q4
$571K Buy
9,541
+91
+1% +$5.45K 0.01% 739
2022
Q3
$427K Sell
9,450
-139,649
-94% -$6.31M 0.01% 836
2022
Q2
$6.65M Buy
149,099
+588
+0.4% +$26.2K 0.17% 151
2022
Q1
$8.4M Buy
148,511
+136,117
+1,098% +$7.7M 0.19% 141
2021
Q4
$643K Buy
12,394
+99
+0.8% +$5.14K 0.01% 793
2021
Q3
$734K Sell
12,295
-25
-0.2% -$1.49K 0.02% 732
2021
Q2
$765K Sell
12,320
-159
-1% -$9.87K 0.02% 703
2021
Q1
$813K Sell
12,479
-150,039
-92% -$9.77M 0.02% 672
2020
Q4
$10.7M Sell
162,518
-11,160
-6% -$734K 0.27% 88
2020
Q3
$8.98M Sell
173,678
-4,610
-3% -$238K 0.25% 101
2020
Q2
$8.78M Sell
178,288
-6,313
-3% -$311K 0.26% 97
2020
Q1
$9.4M Sell
184,601
-20,913
-10% -$1.07M 0.34% 81
2019
Q4
$11.3M Buy
205,514
+1,166
+0.6% +$64.3K 0.31% 86
2019
Q3
$10.3M Sell
204,348
-3,098
-1% -$156K 0.3% 85
2019
Q2
$10.5M Buy
207,446
+148
+0.1% +$7.46K 0.29% 81
2019
Q1
$9.63M Sell
207,298
-2,272
-1% -$106K 0.27% 90
2018
Q4
$10.3M Sell
209,570
-1,739
-0.8% -$85.4K 0.32% 72
2018
Q3
$13.1M Buy
211,309
+7,395
+4% +$459K 0.33% 62
2018
Q2
$11M Buy
203,914
+10,696
+6% +$576K 0.29% 76
2018
Q1
$8.79M Buy
193,218
+15,557
+9% +$708K 0.23% 113
2017
Q4
$6.98M Buy
177,661
+2,423
+1% +$95.2K 0.17% 150
2017
Q3
$6.46M Buy
+175,238
New +$6.46M 0.17% 150
2016
Q3
$6.46M Buy
+175,238
New +$6.46M 0.17% 150